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(170 patients). Angiographic follow-up was performed at a median of 268 (IQR 178-
303) days from the index procedure for 753 (78.9%) lesions. In-stent restenosis rate
was 24.4% of whom 2.8% were defined as late. The cumulative TLR incidence was
31.4% (130 patients). The 8-year survival-free from MACE was 50.7% while survival-
free from TLF was 92.2%. ARC defined definite/probable ST occurred in 12 patients
(cumulative incidence of 3.1%) of whom 2 sub-acute, 1 late and 9 very late. Of these
2 occurred while on DAT and 9/12 patients survived the event.
Conclusion: the implantation of SES in unrestricted clinical practice resulted in a high
8-year survival-free from TLF showing maintained efficacy and efficiency of this
device at very long-term follow-up. MACE attrition remained high mainly due to TVR
as expected in such a complex cohort.
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Background: Chronic total occlusion (CTO) intervention is still challenging because
of the limited procedural success rate and higher target failure. The detailed safety and
efficacy data of CTO intervention in the drug-eluting stent (DES) era from multi center
real world registry are still limited.
Methods: Korean multicenter retrospective CTO registry was collected from Jan 2007
to Dec 2009 and a total of 2961 patients (pts) underwent CTO intervention with DESs
were enrolled from 26 major percutaneous coronary intervention (PCI) centers by
filling out retrospective case report form (CRF). Baseline clinical and procedural
characteristics, major clinical outcomes up to 12 months were evaluated.
Results: The baseline clinical characteristics showed that male were in 73.9%, previous
myocardial infarction (MI) 83.5%, previous PCI 20.5%, hypertension 60.0%, diabetes
35.0%, hyperlipidemia 31.1% and current smoker 26.3%. Myocardial viability test
was done in 13.1% and pre-PCI cardiac CT was done in 15.6%. Lesion distribution
was as follows; RCA 43.0%, LAD 40.6%, LCX 21.8%, LM 0.6% and Ramus 0.4%.
Angiographically unfavorable morphology was in 64.5%. Anterograde approach was
attempted in 96.5% and IVUS guided intervention was done in 25.4%. More than 90%
of the pts received DESs; Sirolimus-eluting stents (SES) 35%, Paclitaxel-ES (PES)
26%, Zotarolimus-ES (ZES) 22%, Everolimus-ES (EES) 11% and others 6%. Overall
procedural success rate was 81.6% (2074/2538 pts) At 12 months, total death was 2.9%,
any MI 1.3%, target lesion revascularization (TLR) 4.4%, target vessel
revascularization (TVR) 7.0%, TLR-major adverse cardiac events (MACEs) 6.5%,
TVR-MACE 10.3% and MACCE 10.6% (Table).
Conclusion: The success rate, safety profile and 12-month cumulative clinical
outcomes of Korean CTO pts following PCI with DES were favorable. Long-term
follow up with larger study population will be necessary to elucidate final conclusion.
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Background: Although the recanalization of chronic total occlusion (CTO) lesions in
native coronary arteries no doubt represents one of the most technically challenging
of interventional procedures, a recently developed hydrophilic floppy wire can allow
us to cross the CTO lesion without any complicated techniques. Multi-slice computed
tomographic coronary angiography (CTCA) provides noninvasive evaluation of the
coronary artery by visualizing vessel trajectory and morphological features at the
occluded site.
Methods: The aim of this study was to evaluate the value of CTCA in predicting the
micro channels most likely to achieve successful guidewire crossing prior to CTO PCI.
Results: Successful wiring with a single soft wire using the antegrade approach was
achieved in 111 lesions (59.4%). Compared to the Control group, the Single group had
more micro contrast infiltration and less stump morphology at the distal end (Table).
Conclusion: Micro contrast Infiltration at the occluded portion and stump morphology
(distal) on CTCA are significant predictors for successful wiring with a single soft
wire. These findings indicate that CTCA could provide practical information to
determine the outcomes of CTO-PCI.
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Background: There are few studies which evaluate the influence of stent length on
long-term clinical outcomes of sirolimus-eluting stent (SES) implantation for chronic
total occlusion (CTO).
Methods: A total of 533 patients with 569 lesions underwent successful CTO
recanalization with SES Implantation between December 2002 and December 2007.
Major adverse cardiac events (MACE) are composed of cardiac death, myocardial
infarction, and target vessel revascularization (TVR). Stent thrombosis (ST) was
identified using the Academic Research Consortium definition. A stratified analysis of
MACE and ST at five years was performed based on the stent length: intermediate
stent group, ≤70 mm and long stent group, >70 mm.
Results: The median follow-up duration was 4.4 years. Kaplan-Meier estimates of
TVR at 5 years were 27.1% vs. 38.1%, p<0.01 (figure). The Cox proportional hazard
analysis identified chronic hemodialysis (adjusted hazard ratio [HR]: 8.77, 95%
confidence interval [CI]: 3.97 to 19.37, p<0.01) and reduced left ventricular ejection
fraction (HR: 2.87, 95%CI: 1.31 to 6.30, p=0.01) as independent predictors of cardiac
death, but not stent length. There was no significant difference in the definite or
probable ST between the two groups (0.6% vs. 2.7%, p=0.08).
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Conclusion: Stent length in SES implantation for CTO was not associated with long-
term cardiac death and ST. The use of longer stent may increase the risk of TVR.
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Background: Subintimal tracking and reentry (STAR) technique has been proposed
in case of failure to cross coronary occlusion (CTO) with conventional approaches.
However concerns on periprocedural myocardial infarction (pMI) and stent thrombosis
(ST) risk have been raised.
Methods: One-hundred-forty-four patients with CTO were treated by STAR technique
in our Institution since March 2004. Successful STAR recanalization (defined as TIMI
3 final flow in the main vessel and in the major side branches) was reached in 93
patients (64.5%), which represent the population of the current study. The decision to
perform elective stenting was left to the operator’s discretion. pMI was defined as an
increase in cardiac biomarkers >3 time above the ULN. All patients were re-evaluated
by coronary angiography within 3 months. ST was defined according to the ARC
criteria. Major adverse event (MACE) at 1 year included death and MI.
Results: Elective stenting was performed in 55 patients (Stent group) whereas POBA
was done in 38 patients (POBA group). The most important clinical and angiographic
characteristics were similar in the 2 groups. The length of the subintimal vessel segment
was shorter in the Stent group (72±35 mm vs 89±33 mm; p = 0.026). Final stent length
was 59±27 mm. pMI occurred more often in the Stent group (50% vs 26%; p = 0.022;
OR = 5.27; 95% CI = 1.15-6.82). Reocclusion at angiographic follow-up was observed
in 14% Stent group and 21% in the POBA group (p = 0.24). ST occurred in 1 patient
(1.8%). MACE at 1 year occurred in 52% in the Stent group and in 26.5% in the POBA
group (p = 0.014) (Figure).
Conclusion: Elective stenting increases the risk of pMI following successful CTO
recanalization by the STAR technique
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Background: To investigate the impact of multivessel disease (MVD) with and
without a concurrent chronic total occlusion (CTO) in a non-infarct related artery (IRA)
on post-procedural myocardial blush grade (MBG) and three-year mortality in patients
with ST-segment elevation myocardial infarction (STEMI) undergoing primary
percutaneous coronary intervention (PCI).
Methods: In the HORIZONS-AMI trial, 3,602 STEMI pts were randomized to
different anticoagulation and stent strategies. Angiographic core lab assessment of the
extent of pre-intervention angiographies coronary artery disease was available in all
patients who underwent primary PCI (n=3,548). Patients were classified as having
single vessel disease (SVD, n=1563, 44%), MVD without a CTO (n=1688, 47.6%), or
a CTO in a non-IRA (n=297, 8%). We investigated post-procedural MBG and early
(<30 days) and late (30 days-3 years) mortality.
Results: Patients with MVD and a CTO in a non-IRA were significantly more likely
to have post-PCI MBG 0/1 compared patients with MVD without a CTO and those
with SVD (12.1% vs. 6.8% vs. 8.0% respectively, p=0.02). MVD with a CTO in a non-
IRA was associated with increased mortality between 0 to 30 days and from 30 days
to 3 years after the index event (Figure 1). After multivariate analysis, a CTO in a non-
IRA was an independent predictor of both early (HR 2.62, 95% CI 1.25-5.50, p=0.01)
and late mortality (HR 1.97, 95% CI 1.19-3.25, p<0.01), while MVD without a CTO
was only a predictor of early mortality (HR 2.20, 95% CI 1.26-3.83, p<0.01).
Conclusion: In this large-scale contemporary multicenter prospective randomized trial,
a CTO in a non-IRA was associated with a higher incidence of MBG 0/1 and
significantly increased early and late mortality. MVD without a CTO was only
associated with increased early mortality.
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Background: Chronic total occlusions (CTO) remain a challenge to treat for
interventional cardiologists not only due to lower acute procedural success but also
higher long-term TLR and MACE rates than non-CTO lesions.
Methods: We compared the performance of biolimus eluting biodegradable polymer
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